# Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients

> **NCT04771299** · PHASE3 · TERMINATED · sponsor: **Lakshmi N Yatham** · enrollment: 1 (actual)

## Conditions studied

- Bipolar I Disorder
- Cognitive Impairment

## Interventions

- **DRUG:** Cariprazine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04771299
- **Lead sponsor:** Lakshmi N Yatham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-07
- **Primary completion:** 2024-09-08
- **Final completion:** 2024-09-08
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Research support no longer available.
- **Last updated:** 2024-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04771299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04771299, "Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04771299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*